Long-Term Treatment With a Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Suppresses Intestinal Tumors in Models of Diabetes and Obesity

被引：0
|
作者：
Fujiwara, Kaori
Yorifuji, Naoki
Nouda, Sadaharu
Kakimoto, Kazuki
Okada, Toshihiko
Kawakami, Ken
Takeuchi, Toshihisa
Inoue, Takuya
Higuchi, Kazuhide
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)32025-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1926
引用
收藏
页码：S591 / S591
页数：1
相关论文
共 50 条
  • [21] NEPHROPATHY EVOLUTION IS PREVENTED BY THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR, SITAGLIPTIN, IN A RAT MODEL OF TYPE 2 DIABETES
    Mega, Cristina
    Reis, Flavio
    de Lemos, Edite Teixeira
    Vala, Helena
    Fernandes, Rosa
    Oliveira, Jorge
    Teixeira, Frederico
    Reis, Flavio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 160 - 160
  • [22] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
    Raz, I.
    Hanefeld, M.
    Xu, L.
    Caria, C.
    Williams-Herman, D.
    Khatami, H.
    DIABETOLOGIA, 2006, 49 (11) : 2564 - 2571
  • [23] Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    Aschner, Pablo
    Kipnes, Mark S.
    Lunceford, Jared K.
    Sanchez, Matilde
    Mickel, Carolyn
    Williams-Herman, Debora E.
    DIABETES CARE, 2006, 29 (12) : 2632 - 2637
  • [24] Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
    Dave, Darshan J.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (04) : 230 - 235
  • [25] Oral ulceration due to a dipeptidyl peptidase-4 inhibitor (sitagliptin): Report of a case
    Jinbu, Yoshinori
    Sase, Miwako
    Kashimura, Kei
    Itoh, Hiroto
    Kusama, Mikio
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2013, 25 (02) : 164 - 166
  • [26] Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats
    Femia, Angelo Pietro
    Raimondi, Laura
    Maglieri, Giulia
    Lodovici, Maura
    Mannucci, Edoardo
    Caderni, Giovanna
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (10) : 2498 - 2503
  • [27] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Deacon, Carolyn F.
    Holst, Jens J.
    ADVANCES IN THERAPY, 2009, 26 (05) : 488 - 499
  • [28] Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Neumiller, Joshua J.
    Campbell, R. Keith
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (18) : 1515 - 1525
  • [29] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Carolyn F. Deacon
    Jens J. Holst
    Advances in Therapy, 2009, 26 : 488 - 499
  • [30] Dutogliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Johnson, Kathryn M. S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (04) : 455 - 463
12345